Background : Guidelines strongly recommend patients with heart failure with reduced ejection
fraction (HFrEF) be treated with multiple medications proven to improve clinical outcomes, …

… For this cross-sectional analysis, we used data at enrollment from the CHAMP-HF (Change
the Management of Patients With Heart Failure) registry: a prospective, observational study …

… This analysis included 4832 outpatients who had chronic HFrEF across 150 practices in the
US in the Change the Management of Patients with Heart Failure (CHAMP-HF) registry with …

… associated with improvements in LVEF, we analyzed patients from CHAMP-HF (Change
the Management of Patients with Heart Failure), a large US registry of outpatients with chronic …

Objectives : The aim of this study was to use a multicenter, observational outpatient registry
of patients with heart failure with reduced ejection fraction (HFrEF) to describe the …

… CHAMP-HF was a registry of outpatients with heart failure (HF) and LVEF ≤40%. Enrolled
… in CHAnge the Management of Patients with Heart Failure (CHAMP-HF), a large multicentre …

… Current heart failure (HF) guidelines recommend the use of … The current study includes
CHAMP‐HF registry patients with … for creatinine) because the CHAMP‐HF registry only includes …

Background: Although a key treatment goal for patients with heart failure with reduced ejection
fraction is to optimize their health status (their symptoms, function, and quality of life), the …

… The CHAMP-HF registry will provide a unique opportunity to study practice patterns and the
adoption of new HF … Heart failure (HF) with reduced ejection fraction (HFrEF) is a significant …

… were enrolled across 152 US sites in the CHAMP-HF registry; 13 were excluded from this …
HF hospitalization within the previous 12 months prior to enrollment in CHAMP-HF (41% vs. 36…